A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition

[1]  R. Dingledine,et al.  The COX-2/prostanoid signaling cascades in seizure disorders , 2018, Expert opinion on therapeutic targets.

[2]  J. C. Baayen,et al.  Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood‐brain barrier dysfunction and seizure progression , 2018, Epilepsia.

[3]  Xin Wu,et al.  Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[4]  Xin Wu,et al.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[5]  W. Löscher,et al.  Blood–Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit , 2018, eNeuro.

[6]  Manisha N. Patel,et al.  Neuroprotective Effects of AEOL10150 in a Rat Organophosphate Model , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  A. Rojas,et al.  Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model , 2018, eNeuro.

[8]  K. Plate,et al.  Functional morphology of the blood-brain barrier in health and disease , 2018, Acta Neuropathologica.

[9]  Brad A. Hobson,et al.  Editor’s Highlight: Spatiotemporal Progression and Remission of Lesions in the Rat Brain Following Acute Intoxication With Diisopropylfluorophosphate , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  R. Dingledine,et al.  Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist. , 2017, ACS chemical neuroscience.

[11]  A. Planas,et al.  Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide , 2017, Journal of Neuroinflammation.

[12]  R. Dingledine,et al.  Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats , 2016, Neuropharmacology.

[13]  R. Ransohoff,et al.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus , 2016, Proceedings of the National Academy of Sciences.

[14]  F. Dudek,et al.  A rodent model of human organophosphate exposure producing status epilepticus and neuropathology. , 2016, Neurotoxicology.

[15]  M. Rogawski,et al.  Models to identify treatments for the acute and persistent effects of seizure‐inducing chemical threat agents , 2016, Annals of the New York Academy of Sciences.

[16]  D. Jett The NIH Countermeasures Against Chemical Threats Program: overview and special challenges , 2016, Annals of the New York Academy of Sciences.

[17]  R. Dingledine,et al.  EP2 Receptor Signaling Regulates Microglia Death , 2015, Molecular Pharmacology.

[18]  H. Brown,et al.  Microarray analysis of the in vivo response of microglia to Aβ peptides in mice with conditional deletion of the prostaglandin EP2 receptor , 2015, Genomics data.

[19]  R. Dingledine,et al.  Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus , 2015, Neuropharmacology.

[20]  Pamela J Lein,et al.  Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury , 2015, Journal of Neuroinflammation.

[21]  V. Aroniadou-Anderjaska,et al.  LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety , 2015, Neuropharmacology.

[22]  C. Aaron,et al.  Organophosphate and carbamate poisoning. , 2015, Emergency medicine clinics of North America.

[23]  F. Dudek,et al.  Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus , 2015, Neuroscience.

[24]  James O. J. Davies,et al.  Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care. , 2014, American journal of respiratory and critical care medicine.

[25]  V. Aroniadou-Anderjaska,et al.  The Limitations of Diazepam as a Treatment for Nerve Agent–Induced Seizures and Neuropathology in Rats: Comparison with UBP302 , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[26]  J. Alves,et al.  4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration. , 2014, Neurotoxicology.

[27]  T. Montine,et al.  PROSTAGLANDIN E2 RECEPTOR SUBTYPE 2 REGULATION OF SCAVENGER RECEPTOR CD36 MODULATES MICROGLIAL AB42 PHAGOCYTOSIS , 2014, Alzheimer's & Dementia.

[28]  V. Aroniadou-Anderjaska,et al.  The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: Relation to anxiety-like behavior , 2014, Neuropharmacology.

[29]  O. Boutaud,et al.  Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling , 2014, The Journal of Neuroscience.

[30]  Raymond Dingledine,et al.  Cyclooxygenase‐2 in epilepsy , 2014, Epilepsia.

[31]  M. Eddleston,et al.  Translational toxicological research: investigating and preventing acute lung injury in organophosphorus insecticide poisoning , 2013, Journal of the Royal Army Medical Corps.

[32]  A. Manning-Boğ,et al.  Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia , 2013, The Journal of Neuroscience.

[33]  V. Aroniadou-Anderjaska,et al.  Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure. , 2013, Neurotoxicology.

[34]  R. Dingledine,et al.  EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia* , 2013, The Journal of Biological Chemistry.

[35]  F. Dudek,et al.  Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation , 2013, Proceedings of the National Academy of Sciences.

[36]  Franco Rossetti,et al.  Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy. , 2012, Neurotoxicology.

[37]  B. Ford,et al.  Spatiotemporal patterns of GFAP upregulation in rat brain following acute intoxication with diisopropylfluorophosphate (DFP). , 2012, Current neurobiology.

[38]  Yun Chen,et al.  Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. , 2012, Neurotoxicology.

[39]  D. Brites,et al.  Neurovascular Unit: a Focus on Pericytes , 2012, Molecular Neurobiology.

[40]  R. Dingledine,et al.  Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2 , 2012, Proceedings of the National Academy of Sciences.

[41]  C. Anacker,et al.  Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy , 2011, Neuroscience Letters.

[42]  R. Dingledine,et al.  Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus , 2011, The Journal of Neuroscience.

[43]  B. Ford,et al.  Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. , 2011, Toxicology and applied pharmacology.

[44]  J. McDonough,et al.  Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage. , 2010, Neurotoxicology.

[45]  L. Tong,et al.  Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague‐Dawley rats , 2010, Epilepsia.

[46]  R. E. Blair,et al.  Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  Wolfgang Löscher,et al.  The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy , 2010, Experimental Neurology.

[48]  G. Snyder,et al.  Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain , 2010, Brain Research.

[49]  C. Pope,et al.  Behavioral sequelae following acute diisopropylfluorophosphate intoxication in rats: comparative effects of atropine and cannabinomimetics. , 2010, Neurotoxicology and teratology.

[50]  K. Andreasson Emerging roles of PGE2 receptors in models of neurological disease. , 2010, Prostaglandins & other lipid mediators.

[51]  E. Aronica,et al.  COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats , 2010, Neuropharmacology.

[52]  E. Ling,et al.  Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE2 in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells , 2009, Neuroscience.

[53]  H. Potschka,et al.  Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition , 2009, Neuropharmacology.

[54]  Heidrun Potschka,et al.  Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling , 2008, Molecular Pharmacology.

[55]  G. Réus,et al.  Acute and subacute exposure to malathion impairs aversive but not non-associative memory in rats , 2007, Neurotoxicity Research.

[56]  D. Jett Neurological aspects of chemical terrorism , 2007, Annals of neurology.

[57]  K. Yamagata,et al.  Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region , 2006, Neuroscience Research.

[58]  T. Montine,et al.  Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[59]  Jun Chen,et al.  Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus , 2005, Brain Research.

[60]  Y. Nishiwaki,et al.  Effects of Sarin on the Nervous System of Subway Workers Seven Years after the Tokyo Subway Sarin Attack , 2005, Journal of occupational health.

[61]  M. Mattson,et al.  Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia , 2005, Annals of neurology.

[62]  Q. Wang,et al.  PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis , 2004, Annals of neurology.

[63]  M. Ross,et al.  Prostanoids, not reactive oxygen species, mediate COX‐2–dependent neurotoxicity , 2004, Annals of neurology.

[64]  L. McCullough,et al.  Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia , 2004, The Journal of Neuroscience.

[65]  R. Dingledine,et al.  Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model , 2003, Experimental Neurology.

[66]  Y. Nishiwaki,et al.  Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. , 2001, Environmental health perspectives.

[67]  G. Lallement,et al.  Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. , 1999, Neurotoxicology.

[68]  William Slikker,et al.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.

[69]  P. Worley,et al.  COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Neil Davies Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine , 1995, Diseases of the colon and rectum.

[71]  T. Babb,et al.  Circuit Mechanisms of Seizures in the Pilocarpine Model of Chronic Epilepsy: Cell Loss and Mossy Fiber Sprouting , 1993, Epilepsia.

[72]  S. Nieminen,et al.  Assessment of acute behavioral toxicity of low doses of diisopropylfluorophosphate (DFP) in rats. , 1991, Methods and Findings in Experimental and Clinical Pharmacology.

[73]  I. Dési,et al.  Behavioral effects of subchronic intoxication with parathion-methyl in male Wistar rats. , 1990, Neurotoxicology and teratology.

[74]  J. McDonough,et al.  Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology , 1987, Brain Research.

[75]  Smith Cd,et al.  Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. , 1986 .

[76]  George Paxinos,et al.  AChE-stained horizontal sections of the rat brain in stereotaxic coordinates , 1980, Journal of Neuroscience Methods.

[77]  R. Dingledine,et al.  Inhibition of the prostaglandin EP 2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus , 2015 .

[78]  M. Lotti,et al.  Organophosphorus and carbamate insecticide poisoning. , 2015, Handbook of clinical neurology.

[79]  A. Smit,et al.  Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. , 2009, Neurotoxicology.

[80]  J. D. De Bleecker Organophosphate and carbamate poisoning. , 2008, Handbook of clinical neurology.

[81]  P. Aas,et al.  Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance. , 2005, Neurotoxicology.

[82]  M. Piga,et al.  [Carbamate and organophosphate poisoning]. , 1996, Minerva anestesiologica.

[83]  M. Murray,et al.  Renal toxicity of the nonsteroidal anti-inflammatory drugs. , 1993, Annual review of pharmacology and toxicology.

[84]  R. Smith,et al.  Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. , 1986, Neurobehavioral toxicology and teratology.